Literature DB >> 10842309

Mammary gland neoplasia: insights from transgenic mouse models.

P M Siegel1, W R Hardy, W J Muller.   

Abstract

Current theories of breast cancer progression have been greatly influenced by the development and refinement of mouse transgenic and gene targeting technologies. Early transgenic mouse models confirmed the involvement of oncogenes, previously implicated in human breast cancer, by establishing a causal relationship between overexpression or activation of these genes and mammary tumorigenesis. More recently, the importance of genes located at sites of loss of heterozygosity in human breast cancer have been examined in mice by their targeted disruption via homologous recombination. The union of these two approaches allows the generation of complex animal models that more accurately reflect the multistep nature of human breast cancer. This review will examine how the study of transgenic mice has increased our understanding of the molecular events responsible for oncogenic transformation of the mammary gland. BioEssays 22:554-563, 2000. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10842309     DOI: 10.1002/(SICI)1521-1878(200006)22:6<554::AID-BIES8>3.0.CO;2-A

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  14 in total

Review 1.  Cell cycle genes in a mouse mammary hyperplasia model.

Authors:  Thenaa K Said; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 2.  Interrogating mouse mammary cancer models: insights from gene expression profiling.

Authors:  Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

3.  Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.

Authors:  M E Kupferman; M E Fini; W J Muller; R Weber; Y Cheng; R J Muschel
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  MEK inhibition suppresses the development of lung fibrosis in the bleomycin model.

Authors:  Maria Galuppo; Emanuela Esposito; Emanuela Mazzon; Rosanna Di Paola; Irene Paterniti; Daniela Impellizzeri; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

Review 5.  Genes, chromatin, and breast cancer: an epigenetic tale.

Authors:  L M Mielnicki; H L Asch; B B Asch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

Review 6.  Probing the microenvironment of mammary tumors using multiphoton microscopy.

Authors:  Mazen Sidani; Jeffrey Wyckoff; Chengsen Xue; Jeffrey E Segall; John Condeelis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

7.  Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.

Authors:  Edward J Gunther; Susan E Moody; George K Belka; Kristina T Hahn; Nathalie Innocent; Katherine D Dugan; Robert D Cardiff; Lewis A Chodosh
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

8.  Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases.

Authors:  Jianqiang Bao; Alessandra Di Lorenzo; Kevin Lin; Yue Lu; Yi Zhong; Manu M Sebastian; William J Muller; Yanzhong Yang; Mark T Bedford
Journal:  Cancer Res       Date:  2018-10-23       Impact factor: 12.701

Review 9.  Linking JNK Activity to the DNA Damage Response.

Authors:  Vincent Picco; Gilles Pagès
Journal:  Genes Cancer       Date:  2013-09

Review 10.  Pre-clinical applications of transgenic mouse mammary cancer models.

Authors:  C J Kavanaugh; K V Desai; A Calvo; P H Brown; C Couldrey; R Lubet; J E Green
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.